Health Care & Life Sciences » Biotechnology | Puma Biotechnology Inc.

Puma Biotechnology Inc.

Puma Biotechnology Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
38.02 M
Public Float
28.39 M
Puma Biotechnology Inc.
Stock Exchange New York Stock Exchange
EPS
$2.61
Market Cap
$471.84 M
Shares Outstanding
38.61 M
Public Float
32.6 M

Profile

Address
10880 Wilshire Boulevard
Los Angeles California 90024
United States
Employees -
Website http://www.pumabiotechnology.com
Updated 07/08/2019
Puma Biotechnology, Inc. is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use.

Financials

View All
Created with Highcharts 5.0.14Puma Biotechnology Inc.Net Income. Fiscal year is January-December. All values USD Thousands.54 65954 659141 965141 965239 284239 284276 011276 011291 955291 955113 575113 575201320142015201620172018050k100k150k200k250k300k350k
Created with Highcharts 5.0.14Puma Biotechnology Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.0000000027 68527 685250 991250 991201320142015201620172018050k100k150k200k250k300k

Alan H. Auerbach
Chairman, President, CEO & Secretary
Michael Patrick Miller
Independent Director